Advanced Cell Technology, a company involved in regenerative medicine, report that its interim chairman and CEO Gary Rabin will be presenting at the World Stem Cells & Regenerative Medicine Congress, May 9-11, in London.

Rabin's presentation, titled "Using ESC-Derived RPE Cells for Dry AMD and Stargardt's Disease," will be given on Monday, May 9.  In it, he will provide an update on ACT's forthcoming human clinical trials for Dry Age-Related Macular Degeneration (Dry AMD) and Stargardt's disease.